Leave Your Message
ADT1436-Nesvacumab Biosimilar-Anti-ANGPT2 mAb-Research Grade
Hot
adt1436-Nesvacumab Biosimilar-Alpha Lifetech.jpg
Loading...
Nesvacumab Biosimilar-Alpha Lifetech.png
Loading...
ALPHA LIFETECH1.png
Loading...
adt1436-Nesvacumab Biosimilar-Alpha Lifetech.jpg
Nesvacumab Biosimilar-Alpha Lifetech.png
ALPHA LIFETECH1.png

ADT1436-Nesvacumab Biosimilar-Anti-ANGPT2 mAb-Research Grade

  • Catalog Number ADT1436
  • Host CHO Cells
  • Species Human
  • Target ANGPT2
  • Application Elisa, WB

ANGPT2 (Angiopoietin 2) is the coding gene for the antagonist of angiopoietin 1 and belongs to the family of angiogenic growth factors. Both angiopoietin-1 and angiopoietin-2 are ligands for endothelial TEK receptor tyrosine kinase. Angiogenesis 2 is upregulated in various inflammatory diseases and is associated with direct control of inflammation related signaling pathways. The encoded protein affects angiogenesis during embryonic and tumor development, disrupts the vascular remodeling ability of pro angiogenic factor 1, and may induce endothelial cell apoptosis. Its related pathways include MIF mediated glucocorticoid regulation and TGF - β pathway. An important homolog of this gene is ANGPT1.

Our biosimilar antibodies are carefully designed to research, ensuring reliability and effectiveness. Available in small or large quantities, they are ideal for both research and commercial applications.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

Angiopoietin-2 is a protein encoded by the human ANGPT2 gene. Angiopoietin-2 encodes a peptide consisting of 496 amino acids, which promotes cell death and disrupts angiogenesis. However, when it binds to vascular endothelial growth factor (VEGF), it can promote the formation of new blood vessels.

Product Specification

Catalog Number

ADT1436

Product Name

ADT1436-Nesvacumab Biosimilar-Anti-ANGPT2 mAb-Research Grade

Alias

REGN-910

Isotype

IgG1

Clonity

Monoclonal

Alternate Names

ANGPT2 antibody, Anti-ANGPT2, Anti-ANGPT2 therapeutic antibody, anti ANGPT2, anti-ANGPT2 antibody, human ANGPT2 antibody, recombinant ANGPT2, ANGPT2 recombinant antibody, ANGPT2 blocking antibody

Official Symbol

ANGPT2

Species

Human

Expression Host

CHO Cells

Reactivity

Human

CAS Number

1296818-77-3

Product Description

Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2.

Mechanism of Action

Nesvacumab is a monoclonal antibody targeting angiopoietin-2 (Ang-2), a protein involved in angiogenesis.

Metabolism

Nesvacumab has a long half-life and is distributed throughout the bloodstream and tissues.

Gene ID

285

Size

1mg,5mg

Research Area

Cancer

Application

Elisa, WB

Purity

>95% as determined by SDS-PAGE

Concentration

Batch dependent

Buffer

Supplied in PBS, PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only. 

Reference

1. Wang B, et al. Genet Test Mol Biomarkers, 2023 Jun. PMID 37382908
2. Kawagishi N, et al. Viruses, 2023 Jan 7. PMID 36680221
3. Yang S, et al. Front Immunol, 2022. PMID 36172371

 

FAQ

Leave Your Message